New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Trial ID or NCT#
NCT01721733
Status
RECRUITING
Purpose
The purpose of this study is to evaluate the effects of EPI-743 in children with Leigh syndrome on disease severity, neuromuscular function, respiratory function, disease morbidity and mortality and disease associated biomarkers.
Official Title
A Phase 2B Randomized, Placebo Controlled, Double Blind Clinical Trial of EPI-743 in Children With Leigh Syndrome
Eligibility Criteria
Ages Eligible for Study: 6 Years to 17 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Gregory Enns
Geneticist
Professor of Pediatrics (Genetics) at the Lucile Salter Packard Children's Hospital
Contact us to find out if this trial is right for you.
CONTACT
Gregory Enns, MD
(650) 498-5798
View on ClinicalTrials.gov